399 related articles for article (PubMed ID: 25423327)
1. North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.
Park H; Qin R; Smith TJ; Atherton PJ; Barton DL; Sturtz K; Dakhil SR; Anderson DM; Flynn K; Puttabasavaiah S; Le-Lindqwister NA; Padula GD; Loprinzi CL
Menopause; 2015 Jun; 22(6):627-32. PubMed ID: 25423327
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
[TBL] [Abstract][Full Text] [Related]
3. A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients.
Park H; Parker GL; Boardman CH; Morris MM; Smith TJ
Support Care Cancer; 2011 Jun; 19(6):859-63. PubMed ID: 21271347
[TBL] [Abstract][Full Text] [Related]
4. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.
Tice JA; Ettinger B; Ensrud K; Wallace R; Blackwell T; Cummings SR
JAMA; 2003 Jul; 290(2):207-14. PubMed ID: 12851275
[TBL] [Abstract][Full Text] [Related]
5. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
Pockaj BA; Gallagher JG; Loprinzi CL; Stella PJ; Barton DL; Sloan JA; Lavasseur BI; Rao RM; Fitch TR; Rowland KM; Novotny PJ; Flynn PJ; Richelson E; Fauq AH
J Clin Oncol; 2006 Jun; 24(18):2836-41. PubMed ID: 16782922
[TBL] [Abstract][Full Text] [Related]
6. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial.
Butt DA; Lock M; Lewis JE; Ross S; Moineddin R
Menopause; 2008; 15(2):310-8. PubMed ID: 17917611
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.
Freeman EW; Guthrie KA; Caan B; Sternfeld B; Cohen LS; Joffe H; Carpenter JS; Anderson GL; Larson JC; Ensrud KE; Reed SD; Newton KM; Sherman S; Sammel MD; LaCroix AZ
JAMA; 2011 Jan; 305(3):267-74. PubMed ID: 21245182
[TBL] [Abstract][Full Text] [Related]
8. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial.
Van Patten CL; Olivotto IA; Chambers GK; Gelmon KA; Hislop TG; Templeton E; Wattie A; Prior JC
J Clin Oncol; 2002 Mar; 20(6):1449-55. PubMed ID: 11896091
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause.
Lewis JE; Nickell LA; Thompson LU; Szalai JP; Kiss A; Hilditch JR
Menopause; 2006; 13(4):631-42. PubMed ID: 16837885
[TBL] [Abstract][Full Text] [Related]
10. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
[TBL] [Abstract][Full Text] [Related]
11. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial.
Pandya KJ; Morrow GR; Roscoe JA; Zhao H; Hickok JT; Pajon E; Sweeney TJ; Banerjee TK; Flynn PJ
Lancet; 2005 Sep 3-9; 366(9488):818-24. PubMed ID: 16139656
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a non-hormonal treatment, BRN-01, on menopausal hot flashes: a multicenter, randomized, double-blind, placebo-controlled trial.
Colau JC; Vincent S; Marijnen P; Allaert FA
Drugs R D; 2012 Sep; 12(3):107-19. PubMed ID: 22852580
[TBL] [Abstract][Full Text] [Related]
13. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; LaVasseur BI; Barton DL; Novotny PJ; Dakhil SR; Rodger K; Rummans TA; Christensen BJ
Lancet; 2000 Dec; 356(9247):2059-63. PubMed ID: 11145492
[TBL] [Abstract][Full Text] [Related]
14. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study.
Pandya KJ; Raubertas RF; Flynn PJ; Hynes HE; Rosenbluth RJ; Kirshner JJ; Pierce HI; Dragalin V; Morrow GR
Ann Intern Med; 2000 May; 132(10):788-93. PubMed ID: 10819701
[TBL] [Abstract][Full Text] [Related]
15. Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population.
Gordon PR; Kerwin JP; Boesen KG; Senf J
Menopause; 2006; 13(4):568-75. PubMed ID: 16837878
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Continuous Transdermal Nitroglycerin for Treating Hot Flashes by Inducing Nitrate Cross-tolerance in Perimenopausal and Postmenopausal Women: A Randomized Clinical Trial.
Huang AJ; Cummings SR; Ganz P; Schembri M; Raghunathan H; Vittinghoff E; Gibson CJ; Grady D
JAMA Intern Med; 2023 Aug; 183(8):776-783. PubMed ID: 37273224
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.
Barton DL; Loprinzi CL; Quella SK; Sloan JA; Veeder MH; Egner JR; Fidler P; Stella PJ; Swan DK; Vaught NL; Novotny P
J Clin Oncol; 1998 Feb; 16(2):495-500. PubMed ID: 9469333
[TBL] [Abstract][Full Text] [Related]
18. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials.
Taku K; Melby MK; Kronenberg F; Kurzer MS; Messina M
Menopause; 2012 Jul; 19(7):776-90. PubMed ID: 22433977
[TBL] [Abstract][Full Text] [Related]
19. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S
Menopause; 2009; 16(2):307-14. PubMed ID: 19194342
[TBL] [Abstract][Full Text] [Related]
20. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
Pinkerton JV; Constantine G; Hwang E; Cheng RF;
Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
